SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

Fei Han; Wen-bin Liu; Jian-jun Li; Ming-qian Zhang; Jun-tang Yang; Xi Zhang; Xiang-lin Hao; Li Yin; Cheng-li Mao; Xiao Jiang; Jia Cao; Jin-yi Liu

doi:10.1530/ERC-18-0529e

SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

Endocr Relat Cancer. 2020 Feb 1;27(2):X1-X2. doi: 10.1530/ERC-18-0529e.

Authors

Fei Han¹, Wen-bin Liu¹, Jian-jun Li², Ming-qian Zhang³, Jun-tang Yang¹, Xi Zhang¹, Xiang-lin Hao¹, Li Yin¹, Cheng-li Mao⁴, Xiao Jiang¹, Jia Cao¹, Jin-yi Liu¹

Affiliations

¹ Institute of Toxicology, College of Preventive Medicine
² Department of Oncology, Southwest Hospital, Army Medical University, Chongqing, China
³ Department of Emergency, Yan’an Hospital, Kunming Medical University, Kunming, Yunnan Province, China
⁴ Department of Pathology, Daping Hospital, Army Medical University, Chongqing, China

PMID: 31995343
DOI: 10.1530/ERC-18-0529e

Abstract

The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303–319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316: